Intelligence · Clinical Development
Pipeline search results
Programs matching “trastuzumab” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 35 pipeline programs matching "trastuzumab" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Trastuzumab in Combination with TS-ONE and cisplatin
Hospital Authority, Hong Kong
Gastric Cancer
1 trial -
pyrotinib and trastuzumab in combinition with neoadjuvant chemotherapy
The First People's Hospital of Lianyungang
HER2-positive Breast Cancer
1 trial -
Subcutaneous Trastuzumab Deruxtecan Phase 1 Trial.
Daiichi Sankyo
Advanced Solid Tumor
1 trial -
Trastuzumab
Hoffmann-La Roche
Early Breast Cancer
1 trial -
Trastuzumab Deruxtecan
Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
1 trial -
trastuzumab [Herceptin]
Hoffmann-La Roche
Healthy Volunteer
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
trastuzumab [Herceptin]
Hoffmann-La Roche
Gastric Cancer
1 trial -
89Zr-trastuzumab
United Therapeutics Europe Ltd
Breast Cancer Metastases
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancers
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.